Literature DB >> 8306979

Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells.

B Bouchard1, V Del Marmol, I J Jackson, D Cherif, L Dubertret.   

Abstract

Pigmentation in mammals is under complex genetic control. Amongst the genes involved in this process, those encoding tyrosinase and the tyrosinase-related-proteins 1 and 2 have been well characterized and share a number of features. Recently, the murine tyrosinase-related-protein-2 gene was shown to encode dopachrome-tautomerase activity and was mapped to the slaty locus. Human tyrosinase and tyrosinase-related-protein-1 genes have been isolated and demonstrate a high degree of similarity with their murine counterparts. However, there has been limited data regarding the existence of a human homologue for tyrosinase-related-protein-2 and its relationship to the other tyrosinase-related proteins. In this study, we report the molecular isolation of a cDNA encoding a human homologue of the murine tyrosinase-related-protein-2/dopachrome tautomerase. We have characterized its expression in human melanocytic cells and have analyzed the relationship between dopachrome tautomerase and tyrosinase activities with the level of visible pigmentation in these cells. TYRP2 has been mapped to the chromosomal region 13q32, thus extending a region of synteny with mouse-chromosome 14.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306979     DOI: 10.1111/j.1432-1033.1994.tb19922.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

Review 1.  Oculocutaneous albinism.

Authors:  S Biswas; I C Lloyd
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

2.  Further evidence to support the melanocytic origin of MDA-MB-435.

Authors:  G Ellison; T Klinowska; R F R Westwood; E Docter; T French; J C Fox
Journal:  Mol Pathol       Date:  2002-10

3.  Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.

Authors:  P Manga; J G Kromberg; N F Box; R A Sturm; T Jenkins; M Ramsay
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

4.  Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.

Authors:  Francesca Avogadri; Sacha Gnjatic; Jodie Tassello; Denise Frosina; Nicole Hanson; Megan Laudenbach; Erika Ritter; Taha Merghoub; Klaus J Busam; Achim A Jungbluth
Journal:  Am J Dermatopathol       Date:  2016-03       Impact factor: 1.533

5.  Pre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy.

Authors:  Hung T Khong; Steven A Rosenberg
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

6.  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.

Authors:  K Yasumoto; K Yokoyama; K Shibata; Y Tomita; S Shibahara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Pigmentation in Black-boned sheep (Ovis aries): association with polymorphism of the MC1R gene.

Authors:  W D Deng; W Shu; S L Yang; X W Shi; H M Mao
Journal:  Mol Biol Rep       Date:  2007-12-13       Impact factor: 2.316

8.  Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.

Authors:  Y T Chen; E Stockert; S Tsang; K A Coplan; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Pigmentation in Black-boned sheep (Ovis aries): association with polymorphism of the Tyrosinase gene.

Authors:  W D Deng; D M Xi; X Gou; S L Yang; X W Shi; H M Mao
Journal:  Mol Biol Rep       Date:  2007-05-23       Impact factor: 2.316

10.  Tetrasomy 13q mosaicism associated with phylloid hypomelanosis and precocious puberty.

Authors:  Shweta U Dhar; Patricia Robbins-Furman; Moise L Levy; Ankita Patel; Fernando Scaglia
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.